NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Magnus Medical

Magnus Medical

Private
Burlingame, CaliforniaHealthcare & Life Scienceshttps://www.magnusmedical.com/

Last Round

Early Stage

VC

May 26, 2026

Total Funding Raised

$90.7M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Magnus Medical is a neurotechnology company that develops non-invasive brain stimulation solutions for treating neurological and psychiatric disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

transcranial magnetic stimulationTMSneuromodulationtreatment-resistant depressionTRDmajor depressive disorderMDDpersonalized neurostimulationMRI-guided TMSaccelerated TMSbrain stimulationintermittent theta-burst stimulationiTBSmental health technologynew technology add-on paymentNTAPCPT codes

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Magnus Medical Comps

Public and private peers based on sector, stage, and business model.

Magnus Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Magnus Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCMay 26, 2026
Series BMay 9, 2025
Series AOct 29, 2021
GrantSep 15, 2020

Magnus Medical Investors

Notable investors and investment history

Magnus Medical investors
InvestorRounds
National Institute of Mental HealthGrant
Dolby Family VenturesSeries B
Khosla VenturesSeries B
NIH RADxGrant
JAZZ Venture PartnersSeries B, Series A
Mubadala Investment CompanySeries B
Red Tree Venture CapitalSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 26, 2026

    $49M raised in early stage VC round

  • Oct 1, 2025

    SAINT® therapy is now FDA authorized for treatment-resistant depression.

Magnus Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Magnus Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Magnus Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersBurlingame, California
Employee Range68
Year Founded2020
Last FundingMay 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.